For instance, in a study on the inhibitor (BGT226) of the phosphoinositide-3-kinase/mammalian target of rapamycin (PI3K/mTOR) signaling pathway, the drug treatment led to cell death via autophagy in head and neck cancer cells [28]. Here, MTOR is linked to head and neck cancer.